Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5
- Citation:
- J Clin Oncol vol 28 (15s) abstr 9017
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. L. Wolf R. Qin S. P. Menon K. M. Rowland Jr J. W. Kugler P. J. Flynn D. Christian D. Satele J. L. Berenberg C. L. Loprinzi
- Networks:
- Study
- NCCTG-N05C5
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: